Study of base influence on intensity of vinpocetine releasing from nasal soft dosage forms

  • N.O. Nagornaya Zaporozhye State Medical University
  • V. V. Gladishev Zaporozhye State Medical University
  • B. S. Burlaka Zaporozhye State Medical University
  • I. L. Kеchin Zaporozhye State Medical University
Keywords: vinpocetine, base, releasing


At present pharmacotherapy is the main component in successful treatment of cerebrovascular pathology. Besides an arsenal of effective medications of conclusive medicine in this area is limited. The one of medications for selective correction of cerebral perfusion is vinpocetine. Defects of its peroral and injection use can be improved by transmucosal vinpocetine administration such as intranasal with suitable semisolid dosage forms. The aim of this work is study of base influence on vinpocetine releasing from nasal semisolid dosage forms. As the carrier for developing vinpocetine nasal semisolid dosage form hydrophilic, hydrophobic and emulsion bases which are used in manufacturing, widely described in literature and don’t provoke any allergic or sensitizing reactions were studied. Further investigation for scientific substantiation choice of base for vinpocetine nasal semisolid dosage form was carried out by the one-factor-at-a-time dispersion design with repeated observations. For all selected compositions the vinpocetine releasing was ascertained with equilibrium dialysis method by Kruvchinsky through cellophane membrane as the first stage of bioavailability evaluation. It was determined that the base makes significant influence on vinpocetine releasing. Dispersion analysis of results presented that emulsion base oil/water provides with the optimal vinpocetine releasing.


1. Varpakhovskaya I.P. Drugs for intranasal use // Medline Express. - 2001. - No. 15 (137). - P. 16-19.
2. Vereshchagin EI, Modern Neuroprotection Opportunities for Acute Brain Circulatory Disorders and Craniocerebral Trauma (Review of Literature), Zh. intensive care. - 2006. - No. 3. - pp. 4-28.
3. Gilman A.G. Clinical Pharmacology. - M .: Practice, 2006. - 434 pp.
4. Kechin I. L. Pharmacological correction of uncomplicated hypertensive crises with antihypertensive drugs for application. Author's abstract. dis ... doc. honey. Sciences: 14.01.28. - K., 2009. - 41 p.
5. Compendium 2012 - Drugs / Ed. V. N. Kovalenko, A. P. Viktorov. - K .: Morion, 2012. - 2385 p.
6. Maltseva L.A., Usenko L.V. Intensive care of ischemic stroke from the standpoint of evidence-based medicine // Ukr. journ extreme honey them G.O. Mozhaeva. - 2005. - Vol. 6, No. 4. - P. 12-16.
7. Cash T. A., Martsenyuk V. P., Kucherenko L. I. and others. Mathematical planning of the experiment in conducting scientific research in pharmacy. - Ternopil: Ukrmedkniga, 2008. - 368 p.
8. Nagorna N. O., Gladyshev VV Study of Pharmacodynamic Properties of Vinpocetine / Mat. 5 sciences-practice. conf. from international with the participation of "Scientific and technological progress and optimization of technological processes for the development of medicinal products". - Ternopil, 2013. - P. 139-140.
9. Chernyi V.I., Ostrovaya T.V., Cherniy E.V., and others. Pathophysiological substantiation of the use of blockers of calcium channels and neurotrophic agents in acute violation of blood circulation of different genesis // Ukr. journ extreme honey them G.O. Mozhaeva. - 2005. - Vol. 6, No. 1 (e). - P. 110-113.
10. Pertsev I. M., Kotenko AM, Chueshov O. V., Khaleeva E. L. Pharmaceutical and biological aspects of ointments. - Kharkiv: Golden Pages, 2003. - 288 p.
How to Cite
Nagornaya, N., Gladishev, V. V., Burlaka, B. S., & KеchinI. L. (2019). Study of base influence on intensity of vinpocetine releasing from nasal soft dosage forms. Farmatsevtychnyi Zhurnal, (2), 64-68. Retrieved from
Pharmaceutical technology